Cerner Launches Unit Targeting Life Sciences

Oct. 26, 2021
Company said it is bringing together expertise, assets and capabilities of Kantar Health with Cerner’s technology and access to a large collection of de-identified patient health data

Health IT vendor Cerner has created a new operating unit called Cerner Enviza to help accelerate discovery, development and deployment of therapies and advance clinical research and the life sciences industry.

In its announcement, Kansas City-based Cerner noted that new therapies can take on average 17 years and $2.5 billion to reach patients. In addition, one study found that only 3 percent of physicians and patients participate in trials.  The company said the new unit was established to “unlock the power of data and a network of research-ready health systems to help get therapies to patients more quickly and at less expense. In addition, a key focus will be on broadening the availability and participation in trials to help achieve more equitable results.”

The true promise of the digital age is to use data to improve everyday health around the world,” said David Feinberg, M.D., president and CEO of Cerner, in a statement. “Healthcare is far too complex, inefficient and expensive. We have to break down industry silos and evolve from simply accumulating data to generating meaningful insights that can accelerate therapy development. With Cerner Enviza, we can arm researchers with diverse tools and datasets to help them address these challenges and help change the way we develop and deliver care for our patients."

The new unit includes Kantar Health, which Cerner acquired in April. It has spent years helping life sciences researchers leverage data – both quantitative and qualitative – to better understand patient and treatment journeys.

The company said it is bringing together the expertise, assets and capabilities of Kantar Health with Cerner’s technology and access to a large collection of de-identified patient health data.

“Our approach unites the life sciences and healthcare providers to support research and trial opportunities across this ecosystem,” said Mike Kelly, global head of Cerner Enviza, in a statement. “The goal is to significantly reduce the timeframe and cost from idea to therapy delivery to help achieve better patient outcomes.”

Sponsored Recommendations

Trailblazing Technologies: Looking at the Top Technologies for the Emerging U.S. Healthcare System

Register for the first session of the Healthcare Innovation Spotlight Series today to learn more about 'Healthcare's New Promise: Generative AI', the latest technology that is...

Data: The Bedrock of Digital Engagement

Join us on March 21st to discover how data serves as the cornerstone of digital engagement in healthcare. Learn from Frederick Health's transformative journey and gain practical...

Northeast Georgia Health System: Scaling Digital Transformation in a Competitive Market

Find out how Northeast Georgia Health System (NGHS) enabled digital access to achieve new patient acquisition goals in Georgia's highly competitive healthcare market.

2023 Care Access Benchmark Report for Healthcare Organizations

To manage growing consumer expectations and shrinking staff resources, forward-thinking healthcare organizations have adopted digital strategies, but recent research shows that...